• Date: February 14, 2019

Judit Cubedo (centre) with GlyCardial Diagnostics team members, Javier Sábado and Lola Fernández.

The 2015 CaixaImpulse selected project Apo J-Glyc, now GlyCardial Diagnostics, has recently received €1.9 million in the SME instrument phase II funding of the Horizon 2020 programme, an initiative of the European Commission. This brings public funding and soft loans raised by the company in the past year to a total of €2.4 million, with grants also obtained from the EIT Health Headstart programme and the Retos-Colaboración project from the Ministerio de Ciencia, Innovación y Universidades.

For Judit Cubedo, the company’s co-founder and CEO, the funding represents an important step in the advancement of the project, which is a spin-off from the Sant Pau Research Institute. “It is amazing and highly motivating to see that the EU trusts in our project as much as we do”, she commented.

GlyCardial Diagnostics is developing a kit for the early diagnosis of cardiac ischemia. The funds they have received will be used to carry out the clinical validation of the novel in vitro test for the early detection of cardiac ischemia, as well as to advance in the development of a fast-test for the rapid detection of its biomarker in blood samples.

“We are about to start the clinical study for the validation of the biomarker. This will be a prospective international study where we will be able to analyse the performance of our novel test in the real clinical setting”, said Judit. “We are very thankful to all our collaborators that have made the project a success.”

More programme highlights

July 31, 2019

Fostering the next generation of biomedical innovators

Earlier this month, the CaixaImpulse team helped organise SHEBUCAR, a two-week training programme coordinated by EIT Health as part of Campus Pilar.

July 24, 2019

Onira Research: offering hope to resistant hypertension patients

We interviewed Onira Research CEO Pablo Campos to find out about the progress of the former CaixaImpulse project.

July 17, 2019

Corify Care: jumping from high impact journals to improving patients’ quality of life

Andreu Climent, CEO of Madrid-based medtech start-up Corify Care, talks about his company’s development of a novel technology that helps treat a serious heart condition.